Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01591603
Other study ID # 120382
Secondary ID
Status Completed
Phase N/A
First received April 23, 2012
Last updated July 17, 2015
Start date May 2012
Est. completion date July 2015

Study information

Verified date July 2015
Source Vanderbilt University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The study will investigate the difference in success rate between popliteal peripheral nerve catheters placed at 1 centimeter compared to 5 centimeters past the tip of a Tuohy needle.


Description:

Traditionally for the lower extremity, peripheral nerve catheters have been threaded greater than or equal to 5 centimeters past the tip of the Tuohy needle. The major rational for this practice is to reduce dislodgement. However, the greater the distance that a catheter is advanced, the greater the risk of contacting undesired structures, kinking, looping and knotting. For the continuous popliteal nerve block, the catheter is threaded perpendicular to the course of the nerve. This could result in the tip of the catheter being a significant distance from the targeted nerve which may lead to a decrease in the success rate or efficacy of the block.

Greater efficacy may be seen if the needle is closer to its target. This may be quantified by documenting a faster onset of motor and sensory changes and/or a lower catheter infusion rate required to maintain pain control. The study will investigate the difference in success rate between popliteal peripheral nerve catheters placed at 1 centimeter compared to 5 centimeters past the tip of a Tuohy needle.


Recruitment information / eligibility

Status Completed
Enrollment 83
Est. completion date July 2015
Est. primary completion date July 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Will be having a popliteal nerve blocks

- Do not meet any of the exclusion criteria listed below.

Exclusion Criteria:

- < 18 years old

- BMI > 35

- Pregnant patients

- Diabetes mellitus or patients with known neuropathy

- Amputations & polytrauma patients

- Patients allergic to local anesthetics

- Chronic Pain patients

- Patients in whom communication is a problem

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
1 cm
A Tuohy needle will be advanced in-plane with the bevel cephalad to a point that lies between the tibial and common peroneal branches of the sciatic nerve. The catheter will be advanced 1 cm past the tip of the Tuohy
5 cm
A Tuohy needle will be advanced in-plane with the bevel cephalad to a point that lies between the tibial and common peroneal branches of the sciatic nerve. The catheter will be advanced 5 cm past the tip of the Tuohy

Locations

Country Name City State
United States Vanderbilt University Medical Center Nashville Tennessee

Sponsors (1)

Lead Sponsor Collaborator
Vanderbilt University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Peripheral block score (PBS). The extent of popliteal nerve blockade will be captured with four sensory groups (sural, superficial peroneal, tibial, and deep peroneal) and three motor groups (superficial peroneal, tibial, and deep peroneal). For each group, a score of 0, 1, or 2 will be assigned based on complete, partial, or no blockade, respectively. The peripheral block score (PBS) outcome variable will be based on the sum of these values and will range from 0 to 14. 10, 20, and 30 minutes after intervention No
Secondary Pain score The investigators will examine the difference in the pain scores (0-10 numeric rating scale) between the two groups. Arrival to PACU (Immediately after surgery, approximately 3-5 hours after intervention) No
Secondary Analgesia failure rate The investigators will examine the difference in analgesia failure rates in the PACU. Analgesia failure is defined as the failure of a rescue bolus (to treat patient pain). Arrival to PACU (Immediately after surgery, approximately 3-5 hours after intervention) No
Secondary Catheter dislodgement rates The investigators will examine the difference in the catheter dislodgement rates. Arrival to PACU (Immediately after surgery, approximately 3-5 hours after intervention) No
Secondary Difference in total opioid usage The investigators will examine the difference in the total opioid usage. We will compare medications separately and in total equivalent units (using an opioid conversion table). Length of Stay In PACU (Approximately 5-7 hours after intervention) No
Secondary Degree of Doppler color agitation The investigators will examine the relationship between the degree of Doppler color agitation (evaluated at the time the catheter is placed) and block success (i.e., the outcome in the primary analysis). Degree of agitation color will be defined as the percentage of nerve covered during the color agitation. Immediately after intervention No
See also
  Status Clinical Trial Phase
Completed NCT01308554 - Pain Relieving Efficacy of TAP Block in Patients After Laparoscopic Gastric Bypass. Phase 4